Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership
CASTRES, France, CAMBRIDGE, Massachusetts and BASEL, Switzerland, March 12, 2025 /PRNewswire/ -- Pierre Fabre Laboratories and RedRidge Bio ('RedRidge') today announced an exclusive R&D collaboration and license agreement to identify and develop biparatopic antibody (BPA) drug candidates against multiple targets. In line with Pierre Fabre Laboratories' innovation strategy, the partnership's therapeutic focus will be on precision oncology as well as dermatology and rare diseases.
Under the terms of the agreement, RedRidge will provide its capabilities to engineer, screen and characterize BPAs against an undisclosed portfolio of jointly nominated targets, while Pierre Fabre Laboratories will provide their drug development expertise to help drive two co-development programs through clinical development. RedRidge will hold exclusive commercial rights in the United States, Canada, and Japan for both programs, while Pierre Fabre Laboratories will hold exclusive rest-of-world rights. In addition, Pierre Fabre Laboratories will hold exclusive worldwide rights for a third program after a hand-off by RedRidge at a preclinical stage.
Financial terms of the agreement are not disclosed but include investment participation by Pierre Fabre Laboratories in RedRidge's Series A financing that will be announced separately, as well as upfront, milestone and future sales royalty payments in addition to funded research payments for Pierre Fabre Laboratories' worldwide program. RedRidge and Pierre Fabre Laboratories will share R&D costs for the co-development programs.
'This strategic alliance attests to the RedRidge team's expertise in innovation and drug discovery for a wide variety of therapeutic targets. We are thrilled to join forces with Pierre Fabre Laboratories as a highly experienced development partner and look forward to building a long-term partnership that synergistically leverages the capabilities of each company,' said Alex Mayweg, PhD, chairperson of RedRidge's board and a managing director at Versant Ventures.
'Pierre Fabre Laboratories are excited to enter into this agreement with RedRidge, which confirms our commitment to collaborate with innovative biotechnology companies. This partnership will allow us to capitalize on RedRidge's cutting-edge expertise in biparatopic antibody drug discovery to deliver high quality clinical candidates on multiple targets addressing oncology, dermatology and rare diseases. It represents a significant milestone in the implementation of our strategy to enrich further our R&D pipeline,' stated Francesco Hofmann, PhD, Head of Research and Development for Medical Care at Pierre Fabre Laboratories.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
3 days ago
- Business Wire
Multiplier Holdings Launches With $27.5 Million in Funding to Accelerate the AI Journey for Professional Services Firms
SINGAPORE--(BUSINESS WIRE)--Today, Multiplier Holdings, a technology company building AI-native professional services firms, publicly launched with $27.5 million in Seed and Series A funding. The Series A round was led by Lightspeed Venture Partners with participation from Ribbit Capital (led the Seed), EDBI, and SV Angel. Multiplier is helping to overcome the AI adoption hurdle by acquiring specialized professional services firms and integrating custom AI automation to deliver better results for clients, drive efficiency and fuel growth. Globally, the professional services market is valued at over $6 trillion, and is projected to grow significantly in the coming years (e.g., tax advisory services are forecasted to grow at 11.2% CAGR). Tax, accounting, specialized advisory and other high-stakes professional services firms face more demand than they can supply with a declining workforce, alongside high labor costs and legacy technologies. Multiplier acquires ambitious boutique services firms, onboards them to its AI-driven practice management platform, and then iteratively and diligently works with the firms' domain experts to uplevel the client experience and improve the scalability of the business. "Vertical SaaS might not be the best path to modernize an industry. Building an AI-native professional services platform from the ground up creates the most technological leverage and captures more incentive alignment between domain and technology experts than traditional SaaS,' said Justin Overdorff, Partner at Lightspeed Venture Partners. 'The Multiplier approach—an AI-first software company acquiring existing service firms to compete directly in the services business by using proprietary technology—allows us to elevate the client and staff experience in a radical way. As it scales, Multiplier can become the preferred buyer in these categories by underwriting the largest and most repeatable post-acquisition improvements to the business while ensuring firm owners and staff participate in the upside." Multiplier partners with the firms it owns to directly embed its technology, iteratively developing new features and offering hands-on technical support as a long-term owner, working alongside the firm's staff to create customized AI-driven solutions to fit the exact needs of each specialized firm. This approach enables Multiplier to build customizable solutions to automate critical but time-consuming tasks and free up time to deliver better outcomes for clients. "We believe the market will reward players who compete on technology-enabled client service through an integrated platform of people and tech. While our portfolio firms maintain operational independence, we align incentives across all stakeholders—from Multiplier leadership to firm leaders and staff—creating hybrid technology firms with exceptional client service, automation, and quality that traditional firms using off-the-shelf AI solutions simply cannot match," said Noah Pepper, CEO of Multiplier Holdings and former Stripe executive. The model is working. Within the first eight months since starting their tech build-out, Multiplier's AI-powered platform helped Citrine International Tax multiply cash flows by approximately 2.5 times and eliminate large swaths of highly manual work. A significant portion of this lift was shared back with the staff of the firm in the form of performance bonuses while delivering enhanced service to clients. "When Noah approached us, we saw Multiplier as a unique opportunity to become part of a technology firm and deliver a truly differentiated level of client service– all while growing the business together," said Gregory Trotman, founder of Citrine International Tax. 'The Multiplier team immersed themselves in our workflows, built a custom end-to-end technology platform and worked with our staff to streamline everything from client onboarding to billing, resulting in a huge lift in productivity.' Clients are noticing the impact of the technology too: 'Citrine has been a major upgrade compared to prior firms we used. Emily, our advisor at Citrine, is more responsive and easier to work with, and the tools she's using help us gain clarity and confidence about where our return is in the workflow - and rapidly confirm when things have been submitted to the authorities,' said Keith Robinson, an American technology investor and former C-level executive living in London who became a Citrine client in the last year. About Lightspeed Venture Partners Lightspeed Venture Partners is a multi-stage venture capital firm focused on accelerating disruptive innovations and trends in AI, Enterprise, Consumer, Health, and Fintech. Over the past 25 years, the Lightspeed team has backed hundreds of entrepreneurs and helped build more than 500 companies globally including Abridge, Affirm, Anthropic, Cato Networks, Epic Games, Glean, Mistral, Moveworks, Navan, Netskope, Rubrik, Snap, Wiz, and more. Lightspeed and its global team currently manage over $30B in AUM across the Lightspeed platform, with investment professionals and advisors in the U.S., Europe, India, Israel, and Southeast Asia. Multiplier Holdings scales high-impact professional services firms through the power of AI. Multiplier's unique model entails acquiring professional services firms, like specialized tax and accounting practices, and transforming them into more scalable, profitable businesses by systematically integrating custom AI solutions. Multiplier holds a library of AI and workflow components developed in-house that can be configured to fit the needs of each acquired firm. This allows Multiplier to automate critical, time-consuming tasks to increase firm efficiency and productivity and drive growth, while improving both the customer and employee experience. To learn more, visit
Yahoo
3 days ago
- Yahoo
Reaction Dynamics Raises CAD $14M in Series A, Reaches CAD $38M in Total Funding
A patented propulsion technology positions Reaction Dynamics as a leader in dedicated orbital launch services, rapid replenishment, and reconstitution of satellite constellations. This funding accelerates the path to the company's first suborbital demonstration flight and the commercialization of its launcher, aimed at commercial and defense satellite markets. LE BOURGET, France, June 18, 2025 /CNW/ - Reaction Dynamics, a Canadian aerospace company based in Québec, announces the closing of its CAD $14 million Series A funding round. This round supports the next phase of development of its hybrid propulsion system, with a first suborbital demonstration flight planned for this winter. The announcement was made at the 2025 International Paris Air Show (SIAE) in Le Bourget. Reaction Dynamics is redefining access to space with a new generation of hybrid launchers. Its technology, designed for deployment from mobile launch infrastructure, offers unprecedented operational flexibility. This innovation serves the commercial sector by enabling fast and efficient replenishment and reconstitution of constellations. It also supports national security applications, including hypersonic platforms. Its hybrid propulsion system, combining solid fuel and liquid oxidizer, stands out for its simplicity, safety, and operational flexibility. The innovative rocket engine drastically simplifies the propulsion architecture, comprising only about a dozen parts compared to nearly 15,000 in traditional liquid-fueled engines. This type of fuel and oxidizer eliminates explosion risks, increasing safety during both ground and flight operations. Reaction Dynamics' Aurora-8 rocket targets the growing market of small satellites under 200 kilograms, offering affordable, rapid, and precise launches into targeted orbits. The company aims to serve both commercial and defense markets. Since its founding in 2017, Reaction Dynamics has successfully completed all major validation milestones of its now-patented technology, with full-system testing underway and a maiden flight expected this winter. This new investment adds to a CAD $10 million grant from the Government of Québec announced last week, as well as previous seed funding, tax credits, and other public support, bringing the total funds raised to date to CAD $38 million. This substantial injection marks a turning point in the company's growth, allowing it to accelerate operations and scale its launch solutions internationally, at a time when space sovereignty is emerging as a strategic national issue. Quote: "We have a clear growth trajectory, with engine testing underway to validate our hybrid propulsion system. A suborbital demonstration flight is scheduled for this winter – a key milestone to demonstrate our technology under real conditions, even though engine reliability is already proven. This funding round will move us closer to commercial deployment and solidify our role as a key player in the Quebec and Canadian space ecosystem," said Bachar Elzein, CEO and CTO of Reaction Dynamics. About Reaction Dynamics Reaction Dynamics is a Quebec-based aerospace company founded in 2017 and headquartered in Longueuil. It specializes in the design of hybrid rockets. With its patented technology that simplifies and secures space launches, Reaction Dynamics offers flexible, cost-effective solutions to quickly deploy small commercial and defense satellites into orbit. The company is contributing to building a dynamic space sector in Quebec while addressing the growing global demand for rapid, on-demand access to space. SOURCE Reaction Dynamics Lab Inc. View original content:
Yahoo
3 days ago
- Yahoo
Pierre Fabre Laboratories Begins Next Chapter in Secaucus, NJ
SECAUCUS, N.J., June 18, 2025 /PRNewswire/ -- Pierre Fabre Laboratories, a global healthcare company originated from France, announces the inauguration of its new US office located on 500 Plaza Drive, in Secaucus, NJ which will host its dermo-cosmetics and medical care subsidiaries. Pierre Fabre is the world's second-largest dermo-cosmetics manufacturer and a global player in oncology, cell & gene therapy, rare disease and dermatology. This strategic move in the US marks a pivotal moment in the company's growth strategy, underscoring its strong commitment to advancing in the US in both dermo-cosmetics and medical care. Pierre Fabre Laboratories introduced global dermo-cosmetics brands Avène, Klorane and René Furterer to the US market in the 1990's. With an ever-growing desire for French dermo-cosmetics, the US dermo-cosmetics business has become a top priority. Building upon their success in oncology and dermatology in Europe and Asia, the company has recently expanded its medical care investments in the US through the creation of a dedicated pharmaceutics unit, Pierre Fabre Pharmaceuticals (PFP). This subsidiary is focused on continuing to deliver breakthrough therapies in rare diseases and oncology to American patient populations with high unmet needs and limited treatment options. Eric Ducournau, CEO of Pierre Fabre Laboratories states, "we have declared the United States a priority geography for the company. The US is not only the biggest market in the world for pharmaceuticals and cosmetics alike, but also the most disruptive market for therapeutic innovation. For 15 years, we have built strategic partnerships with highly innovative US biotechnology companies in the fields of oncology, rare diseases, and medical dermatology. We have also multiplied by 10 times the turnover of our blockbuster brand Eau Thermale Avène since 2010, and its potential remains huge given the growing appetite of American consumers for cosmetics designed and tested with the same rigor as for medicines. We are now determined to walk the next step forward and the opening of our new office in Secaucus with plans to expand in the rare diseases and oncology business is a testimony to this dedication." Secaucus, NJ offers a strategic location with excellent transportation links to New York City and the broader tri-state area. Designed to represent the company's core values, the office showcases its deep respect for the environment, a commitment to sustainable innovation and allows for hands on learning through an onsite space that offers an immersive skin and hair care experience. This thoughtfully curated environment is engineered to spark creativity and foster teamwork across all departments. "This new office is more than just a space, it's a hub for collaboration, innovation, and showcases the team's hard work and dedication. It embodies the Group's commitment to pushing boundaries across both business units in derm-cosmetics and pharmaceutics, while providing New Ways to Care for all" said Lisa Morris, President and CEO of Pierre Fabre USA. "Today's office opening demonstrates the steadfast commitment of Pierre Fabre Laboratories to building a powerful presence for medical innovation and patient impact in the US," said Adriana Herrera, CEO of PFP. "Leveraging our strength as a humanitarian foundation owned company, PFP has been focused over the past 18-months on building the US Medical Care operations and to bring on board an experienced, agile and purpose driven US team focused on creating long-term value and hope for patients, by delivering innovative therapies to people living with cancer who are in urgent need of effective, life-extending treatment options." With this new footprint in the US, Pierre Fabre Laboratories is positioning itself for even greater impact with American patients and healthcare professionals in dermo-cosmetics and pharmaceuticals. For the company, this is only the beginning. For more information, visit or follow @aveneusa on Instagram Note: High-resolution images, interviews, and product samples are available upon request. ABOUT PIERRE FABRE LABORATORIES Pierre Fabre Laboratories is the world's second-largest dermo-cosmetics company and one of Europe's leading pharmaceutical laboratories. Its Dermo-cosmetics & Personal Care portfolio includes international brands such as Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer, Même Cosmetics, Darrow, and Elgydium. Its Medical Care activity covers 5 main therapeutic fields: oncology, dermatology, rare diseases, primary care, and family health care. In 2024, Pierre Fabre Laboratories posted 3.1 billion euros in revenues, 70% of which came from international sales in 120 countries. Based in southwest France since its creation and manufacturing nearly 90% of its products in France, Pierre Fabre Laboratories employs 10,200 people worldwide. Its R&D budget amounted to 220 million euros in 2024, of which 60% is allocated to targeted therapies in oncology and 35% to skin health and care solutions. Pierre Fabre Laboratories' majority shareholder (86%) is an eponymous humanitarian Foundation. Employees constitute the company's other shareholders. This capital structure guarantees the company's independence, long-term vision, and contribution to the common good. The dividends paid to the Pierre Fabre Foundation contribute to 35 healthcare-access programs deployed in 22 of the least developed countries in the world. Pierre Fabre Laboratories' CSR policy has been assessed by AFNOR Certification and has been awarded the "Exemplary" level of its CSR label (ISO 26 000 standard for sustainable development). For more information, visit Media Contact:Elena Suarez-Peñ View original content to download multimedia: SOURCE Avène USA
